HeLaXON 1X

A digital therapeutic device for mild cognitive impairment optimized for German patients. Designed to delay cognitive function deterioration through periodic monitoring and customized cognitive training. Undergoing Digital treatments and medical applications (DiGA) fast track approval process in Germany through BfArM regulatory body, enabling rapid market entry and high insurance reimbursement rates.

A dementia treatment system that combines Transcranial Magnetic Stimulation (TMS) electronic medicine technology with digital therapeutics cognitive learning programs. It is the first treatment device in Korea that integrates an electromagnetic stimulator with a dementia learning program by applying proprietary artificial intelligence image analysis and robot control technology. The device is currently undergoing confirmatory clinical trials.

An integrated phototherapy system combining wearable light therapy glasses with a mobile application for cognitive wellness management. The system is indicated for patients concerned with cognitive decline, age-related memory loss, and early-stage neurodegenerative conditions.

A therapeutic device designed for auxiliary treatment of brain diseases, including brain tumors. The device is developed with core technology focused on blood-brain barrier penetration and represents the company's work in brain disease medical applications.

Non-invasive, home-based neuromodulation device for treating early to moderate Alzheimer's disease through personalized electrical stimulation targeting glial cells. Enables patient self-administration in home setting.

A therapeutic device for Alzheimer's disease treatment using transcranial magnetic stimulation technology. It is designed to address cognitive and neurological symptoms associated with Alzheimer's disease.

Advanced electronic therapy system for psychiatry and neurology applications. Delivers precision stimulation for neurological disorder management. Clinical-grade device for hospital and specialized medical facilities.

Innovative therapeutic technology designed to enhance the brain's natural cleaning system for improved neurological function. The device targets neurodegenerative processes through biological optimization.

A newly launched medical device by Nihon Kohden for clinical use. The product contributes to advanced medical care and diagnosis.

Neuroelectrics is a leading innovator in the field of medical devices, neurotechnology, specialising in non invasive brain stimulation, monitoring and EEG analysis. It provides a unique and flexible suite of services designed to meet the needs of hospitals and pharmaceutical companies. By combining high-quality EEG headsets, advanced digital tools and expert clinical insights, it delivers precise data collection and analysis to streamline your clinical diagnosis and clinical trials. From custom protocol development and participant selection to EEG interpretation, its solutions save time, reduce costs, and enhance the quality and outcomes of your studies. Neuroelectrics holds 3-5 patents and 1 trademark and complies with the ISO 13965, MDSAP, Medical CE marking (EU and Canada), and FDA 510K standards.

AI-powered predictive neurorehabilitation platform integrating augmented reality, functional electrical stimulation (FES), neuromuscular electrical stimulation (NMES), and BioRhythmIQ technology for personalized motor recovery. The system features predictive intent decoding algorithms, AI-driven adaptation of therapy parameters, and immersive AR-guided therapy to support advanced neurological rehabilitation.

Healaon Pro is a non-invasive vagus nerve stimulation (VNS) device designed in a portable, smartphone-like format for convenient at-home use. The device delivers therapeutic stimulation for managing chronic conditions including migraines, seizures, and other neurological disorders. Its handheld design enables accessible neuromodulation therapy without surgical implantation.